Summit Therapeutics stock catapulted Tuesday after AstraZeneca made a $2 billion investment in the smaller biotech. The post AstraZeneca Digs $2 Billion Out Of Its Coffers For Summit Deal, Taking On Bristol, Pfizer, Merck appeared first on Investor's Business Daily.
CryptoAlerta — análise de criptomoedas e mercado em tempo real